Oracle Wins Bid for TikTok in U.S., After Microsoft Proposal RejectedThe Wall Street Journal Microsoft’s offer to buy US TikTok is rejectedCNN TikTok picks Oracle over Microsoft in Trump-forced sales bidThe Associated Press Oracle Chosen as TikTok’s Tech Partner, as Microsoft’s Bid Is RejectedThe New York Times Oracle boots out Microsoft and wins bid to […]
Business
Gilead to buy cancer drugmaker Immunomedics in $21 billion deal – CNBC
Gilead to buy cancer drugmaker Immunomedics in $21 billion dealCNBC Gilead to acquire Immunomedics for $21 billionCNN Gilead Reaches Deal to Buy Immunomedics for $21 BillionThe Wall Street Journal Gilead Nears $20 Billion Deal for Immunomedics, WSJ SaysmsnNOW Gilead Ramps Up Cancer Focus With $21 Billion Immunomedics DealBloomberg View Full Coverage on Google News
Pfizer CEO says coronavirus vaccine could be distributed to Americans before year’s end – Fox Business
Pfizer CEO says coronavirus vaccine could be distributed to Americans before year’s endFox Business Pfizer CEO says company will know if vaccine works by end of OctoberFace the Nation Pfizer coronavirus vaccine could be given to Americans before end of the year, CEO saysCNBC Pfizer, BioNTech look to expand late-stage COVID-19 vaccine trialFox Business Pfizer […]
SoftBank is close to selling off chipmaker Arm to Nvidia in $40 billion mega-deal – Business Insider – Business Insider
SoftBank is close to selling off chipmaker Arm to Nvidia in $40 billion mega-deal – Business InsiderBusiness Insider SoftBank Nears $40 Billion Deal to Sell Arm Holdings to NvidiaThe Wall Street Journal SoftBank is reportedly preparing to sell ARM to Nvidia for more than $40 billionThe Verge Nvidia acquistion of ARM all but a done […]
AstraZeneca says trials of coronavirus vaccine resume – Reuters
AstraZeneca says trials of coronavirus vaccine resumeReuters Oxford, AstraZeneca resume coronavirus vaccine trialFox Business First batch of Sputnik V vaccine has been shipped to Russian regions – Health MinistryTASS AstraZeneca coronavirus vaccine clinical trials resume in U.K. after pause over safety concernsCNBC What Went Wrong with AstraZeneca’s Vaccine Trial? CEO Only Shares Details with InvestorsDemocracy […]